# Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA

> **NCT04732637** · — · UNKNOWN · sponsor: **Datar Cancer Genetics Limited** · enrollment: 300 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Test At Home's Proprietary "Lollipop" Buccal Cavity Swab

## Key facts

- **NCT ID:** NCT04732637
- **Lead sponsor:** Datar Cancer Genetics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-31
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04732637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04732637, "Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04732637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*